The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Using cell-free DNA to predict response to immunotherapy in non-small cell lung cancer pre- and post-treatment.
 
Satyanarayan Rao
Patents, Royalties, Other Intellectual Property - Signatures in cell-free DNA to detect disease, track treatment response, and inform treatment decisions (Inst)
 
Alexis Zukowski
Stock and Other Ownership Interests - 10x Genomics; Moderna Therapeutics
Patents, Royalties, Other Intellectual Property - Signatures in cell-free DNA to detect disease, track treatment response, and inform treatment decisions (Inst)
 
Abigail Weirich
No Relationships to Disclose
 
Peter Kabos
Research Funding - Angiochem (Inst); AstraZeneca (Inst); Genentech (Inst); Lilly (Inst); Pfizer (Inst); Radius Health (Inst); Sanofi (Inst)
Patents, Royalties, Other Intellectual Property - Signatures in cell-free DNA to detect disease, track treatment response and inform treatment decisions. (Inst)
 
Elin Marie Stensland
Consulting or Advisory Role - Sanofi
 
Inger Johanne Zwicky Eide
No Relationships to Disclose
 
Odd Terje Brustugun
Honoraria - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; MSD Oncology; Novartis; Pfizer; Sanofi/Regeneron
Consulting or Advisory Role - Bayer Health (Inst); MSD Oncology (Inst); Roche (Inst); Takeda (Inst)
Research Funding - Abbvie (Inst); Amgen (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst)
 
Srinivas Ramachandran
Patents, Royalties, Other Intellectual Property - Signatures in cell-free DNA to detect disease, track treatment response, and inform treatment decisions (Inst)